Effect and safety of PCSK9 inhibitor in-hospital use on blood lipid level in the ACS patients: a systematic review and meta-analysis
Event:
Frontiers in CardioVascular Biomedicine 2024
Topic:
Lipid Metabolism, Metabolic Syndrome, Diabetes
Session:
Poster session 2
